A detailed history of Ars Wealth Advisors Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ars Wealth Advisors Group, LLC holds 155,851 shares of MRK stock, worth $19.6 Million. This represents 2.8% of its overall portfolio holdings.

Number of Shares
155,851
Previous 144,061 8.18%
Holding current value
$19.6 Million
Previous $15.7 Million 30.94%
% of portfolio
2.8%
Previous 2.34%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $1.34 Million - $1.56 Million
11,790 Added 8.18%
155,851 $20.6 Million
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $4.52 Million - $4.92 Million
45,138 Added 45.63%
144,061 $15.7 Million
Q3 2023

Oct 26, 2023

SELL
$102.95 - $114.33 $207,959 - $230,946
-2,020 Reduced 2.0%
98,923 $10.2 Million
Q2 2023

Jul 18, 2023

SELL
$108.61 - $118.38 $395,774 - $431,376
-3,644 Reduced 3.48%
100,943 $11.6 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $203,100 - $226,618
1,973 Added 1.92%
104,587 $11.1 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $769,821 - $987,016
-8,804 Reduced 7.9%
102,614 $11.4 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $9.42 Million - $10.6 Million
111,418 New
111,418 $9.6 Million
Q3 2022

Nov 08, 2022

SELL
$84.53 - $94.96 $9.17 Million - $10.3 Million
-108,430 Closed
0 $9.6 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $101,356 - $114,892
1,214 Added 1.13%
108,430 $9.89 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $5,660 - $6,344
77 Added 0.07%
107,216 $8.8 Million
Q4 2021

Feb 08, 2022

BUY
$72.28 - $90.54 $451,894 - $566,056
6,252 Added 6.2%
107,139 $8.21 Million
Q3 2021

Oct 26, 2021

BUY
$71.68 - $78.83 $7.23 Million - $7.95 Million
100,887 New
100,887 $7.58 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ars Wealth Advisors Group, LLC Portfolio

Follow Ars Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Wealth Advisors Group, LLC with notifications on news.